Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04756076 · ClinicalTrials.gov registry record
Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients
A clinical trial of Pulmonary Hypertension and Metal Poison, sponsored by Jiapeng Huang.
- Recruiting
- Registry status
- 110
- Enrollment target
- 1
- Study location
NCT04756076 is a study of Pulmonary Hypertension and Metal Poison that is actively recruiting participants, run by Jiapeng Huang. The registered enrollment target is 110 participants, below the 612-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04756076, a study of Pulmonary Hypertension and Metal Poison, is actively recruiting participants, sponsored by Jiapeng Huang.
- RECRUITING
- Registry status
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators plan to recruit 50 PAH patients from UofL PAH Clinic, with various degrees of severity (25 intermediate risk patients and 20 high risk patients) and 10 age and gender matched controls. PAH patients are evaluated at least every 6 months by the PAH Clinic and blood/urine samples will be obtained at each office visit. Blood, plasma and urine samples will be used to measure 31 metal levels including heavy metals (cadmium, arsenic, cobalt, lead etc.) and essential metals (calcium, copper, iron, zinc, potassium etc.) by the with ICP-MS via the service of ITEMFC. Interactions among the 31 metals in PAH patients, metal concentration differences between intermediate risk PAH, high risk PAH and control groups, the correlation between metal concentrations and the etiology, severity, duration, treatment, and progression of PAH/RV dysfunction over 12 months will be analyzed by CIEHS Biostatistics and Informatics Facility Core.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Metal level measurements
Study Locations (1)
Kentucky
- University of Louisville Health - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2020-12-02 |
| Est. Completion | 2029-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04756076
The ClinicalTrials.gov registry entry for NCT04756076 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 612-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (82% lower). The listed sponsor is Jiapeng Huang, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Metal level measurements is the first listed.
NCT04756076 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT04756076 about?
NCT04756076 is a clinical study titled "Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients". Investigators plan to recruit 50 PAH patients from UofL PAH Clinic, with various degrees of severity (25 intermediate risk patients and 20 high risk patients) and 10 age and gender matched controls. PAH patients are evaluated at least every 6 months by the PAH Clinic and blood/urine samples will be ...
What is the current status of trial NCT04756076?
This trial is currently recruiting. The enrollment target is 110 participants. The study started on 2020-12-02. Estimated completion is 2029-12-31.
What conditions does trial NCT04756076 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Metal Poison.
What interventions are being tested in trial NCT04756076?
The interventions under investigation include: Metal level measurements (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04756076?
This trial is sponsored by Jiapeng Huang, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04756076 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
RECRUITING
-
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
RECRUITING
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
RECRUITING
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.